You are here:

Archived: tiotropium (Spiriva-Respimat)

Advice

Following an abbreviated submission

tiotropium respimat inhaler (Spiriva Respimat®) is accepted for restricted use within NHS Scotland as maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease.

It may be used for patients in whom tiotropium is an appropriate choice of maintenance bronchodilator treatment but it is restricted to patients who have poor manual dexterity and therefore have difficulty using the Handihaler device.

Drug Details

Drug Name: tiotropium (Spiriva-Respimat)
SMC Drug ID: 411/07
Manufacturer: Boehringer Ingelheim Ltd
Indication: Chronic Obstructive Pulmonary Disease
BNF Category:
Sub Category: 3.1 Bronchodilators
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 12 November 2007

Current Advice

Abbreviated Submission 11 December 2017

Back